Ciara Keenan is a Research Fellow at Queen’s University Belfast with an established international reputation in evidence synthesis methodology. Systematic review projects have demonstrated her expertise in the intersections of health, social welfare, disability, and education. Prior to joining Campbell UK and Ireland, Ciara was employed by Kleijnen Systematic Reviews (KSR) to work on projects for the healthcare industry, two of which have informed NICE guidelines.
Ciara earned an MSc with distinction having used evidence synthesis methodology as far back as 2013. Shortly thereafter she was awarded a full scholarship to pursue a PhD using evidence synthesis methods, which was completed in 2018.
Ciara is most committed to capacity building in evidence synthesis which has led to her work as Founder and Editor of the meta-evidence blog and twitter’s @evidencerobot and @COVID_Evidence. Ciara provides regular training and workshops across various evidence synthesis topics and is currently leading review teams on several projects including a network meta-analysis. In conjunction with these roles, Ciara is currently Co-Convenor of the Campbell Collaboration’s Information Scientist Network, a Methods Editor and Information Retrieval specialist for Campbell’s Education Coordinating Group (ECG).
PhD in Education and Psychology, 2018
Queen's University Belfast
MSc in Autism Spectrum Disorders, 2013
Queen’s University Belfast
BSc (Hons) in Psychology, 2009
University of Ulster, Coleraine
Current and most previous experience
A small selection of current projects
Accommodation-based interventions for individuals experiencing, or at risk of experiencing, homelessness: a network meta-analysis.
An overview of the best practice guidelines for all research synthesis and to detail additional specific considerations and methodological details for the best practice of conducting a rigorous meta-review (sometimes called an Umbrella review).
Obinutuzumab for untreated advanced follicular lymphoma ID1020
A systematic review of randomised controlled trials in education
Glecaprevir-pibrentasvir for treating chronic hepatitis C